The institute's clinical center of gravity is the digestive tract. The problem it works hardest on is how to cure a cancer without removing the organ. An esophagus or a stomach can be taken out. For advanced disease that is still the right operation. But the cost to a patient's swallowing, eating, and weight is permanent. When a tumor is caught while it is still confined to the lining, it can often be lifted off from the inside instead. The method is called endoscopic submucosal dissection. A doctor passes an endoscope, a thin tube with a camera, down the throat. Fluid is injected under the lesion to raise it off the muscle layer beneath. The lesion is then cut away in one piece, so a pathologist can confirm that the edges are clear of cancer. The organ stays.
Esophageal cancer is where this shows most clearly. The institute operates on roughly 170 esophageal cancers a year. It treats a substantial further number through an endoscope. Some patients would otherwise face having the whole esophagus removed. In selected cases chemoradiotherapy can be curative on its own. That means chemotherapy and radiation given together. Removing the tumor through an endoscope can also be combined with it, to raise the chance of clearing the cancer. For some esophageal tumors the institute uses photodynamic therapy. That includes tumors that have come back in the same place after chemoradiotherapy. The patient is given a light-sensitive drug that concentrates in tumor tissue. A laser passed through the endoscope then activates it.
Across all sites the hospital performs roughly 4,270 operations a year. That includes laparoscopic and thoracoscopic surgery, done through small cuts in the abdomen or the chest with a camera. Radiation oncology runs external beam treatment shaped to the tumor. It includes intensity-modulated radiation therapy, which shapes the dose so it bends around the organs that must be spared. It also includes brachytherapy, which places the radiation source inside the body directly against the tumor. That is standard in cancers of the female reproductive organs. Hematology covers chemotherapy, blood stem cell transplant, and cell-based therapy for leukemia, lymphoma, and myeloma. Departments span the digestive system, the lungs, the female reproductive organs, the urinary system, head and neck surgery, and breast cancer. Intensive care and high-care beds back them up.
Two further things shape what is available on this site. The Osaka Heavy Ion Therapy Center opened in the same Otemae district in 2018. It states that it provides carbon-ion treatment in cooperation with the institute next door. So a carbon-ion option can be weighed without sending a patient out of the district. The second thing goes back to the founding. This institution began as a combined cancer and cardiovascular center. It kept the heart and blood vessel capability that most standalone cancer hospitals do not have. That matters for older patients whose heart disease would otherwise narrow what the cancer doctors can offer. Palliative care is provided as an outpatient service here rather than as an inpatient ward. The cancer consultation support center is open to patients and families from other hospitals as well as its own.